PP2A-B56-γ Antibodies

Santa Cruz Biotechnology delivers a wide array of PP2A-B56-γ monoclonal antibodies for research focused on understanding cellular regulation mechanisms. PP2A-B56-γ Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PP2A-B56-γ is a regulatory subunit of the protein phosphatase 2A (PP2A) complex, which plays a vital role in numerous cellular processes, including cell growth, division, and apoptosis. By modulating the phosphorylation state of various substrates, PP2A-B56-γ is essential for maintaining cellular homeostasis and signaling pathways. PP2A-B56-γ has emerged as a significant focus in cancer research due to its role in cell cycle regulation and tumor suppression. Understanding PP2A-B56-γ function has become increasingly important as research reveals its involvement in various signaling cascades and cellular mechanisms. Recent studies have highlighted PP2A-B56-γ's potential as a therapeutic target in multiple disease states. Investigating PP2A-B56-γ's regulatory mechanisms provides valuable insights into fundamental biological processes and disease development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PP2A-B56-γ's role in health and disease.